| Segment Reporting |
14.
Segment Reporting
The
Company’s only segment is Clinical Stage Biotechnology. The CODM reviews profit and loss information on a consolidated basis in
order to assess performance and make decisions about the allocation of operating and capital resources.
The
following table presents disaggregated financial information with respect to the Company’s Clinical Stage Biotechnology segment
for the three months ended March 31, 2026 and 2025, respectively:
Schedule
of Segment Reporting Information
| | |
2026 | | |
2025 | |
| | |
For the Three Months Ended | |
| | |
March 31, | |
| | |
2026 | | |
2025 | |
| | |
| | |
| |
| Grant Revenue | |
$ | - | | |
$ | 278,628 | |
| Operating Expenses: | |
| | | |
| | |
| Research and development | |
| | | |
| | |
| Clinical trial and research expenses | |
| 189,138 | | |
| 250,496 | |
| Insurance | |
| 39,663 | | |
| 47,989 | |
| Payroll and taxes | |
| 78,017 | | |
| 82,179 | |
| Stock based compensation | |
| 13,342 | | |
| 13,894 | |
| Rent and utilities | |
| 9,064 | | |
| 8,146 | |
| Travel and entertainment | |
| 4,110 | | |
| - | |
| Total research and development | |
| 333,334 | | |
| 402,704 | |
| General and administrative | |
| | | |
| | |
| Depreciation | |
| 466 | | |
| 466 | |
| Directors fees | |
| 77,500 | | |
| 77,500 | |
| Donations | |
| - | | |
| 50,000 | |
| Insurance | |
| 35,305 | | |
| 26,760 | |
| Legal fees | |
| 143,351 | | |
| 121,022 | |
| Other general and administrative expenses | |
| 27,631 | | |
| 16,872 | |
| Payroll and taxes | |
| 221,673 | | |
| 216,713 | |
| Professional fees | |
| 109,955 | | |
| 158,627 | |
| Rent and utilities | |
| 5,294 | | |
| 4,651 | |
| Stock based compensation | |
| 292,709 | | |
| 301,206 | |
| Travel and entertainment | |
| 685 | | |
| - | |
| Foreign currency transaction losses | |
| - | | |
| 48 | |
| Total general and administrative | |
| 914,569 | | |
| 973,865 | |
| Total Operating Loss | |
| (1,247,903 | ) | |
| (1,097,941 | ) |
| Other Expense: | |
| | | |
| | |
| Interest expense | |
| (53,046 | ) | |
| (63,661 | ) |
| Net Loss | |
$ | (1,300,949 | ) | |
$ | (1,161,602 | ) |
Other
general and administrative expenses primarily include costs associated with office expenses, bank charges, computer-related expenses,
dues and subscriptions, and taxes. These expenses are incurred as part of the day-to-day operations and general administration of the
Company’s segment.
|